Venlafaxine is a serotonin and noradrenaline reuptake inhibitor. At lower doses it acts mainly on serotonin, like an SSRI; as the dose rises, noradrenaline reuptake is increasingly blocked too. That dual action makes it useful for people who have not responded to an SSRI, and it brings two specific characteristics: it raises blood pressure in a dose-dependent way, and it causes the most difficult discontinuation symptoms of any antidepressant in common use.
Follow the instructions on your label. This guide contains no doses. Do not stop it abruptly.
Blood pressure
The noradrenaline effect raises blood pressure, and the rise is dose-related - modest at lower doses and more significant at higher ones.
Blood pressure should be checked before starting and monitored during treatment, particularly after each dose increase. Uncontrolled hypertension is a reason to use something else, and a sustained rise on treatment may require a dose reduction or a switch.
A pharmacy blood pressure check between appointments is an easy way to keep an eye on it - see pharmacy health checks.
Heart rate also rises modestly. Tell your prescriber about any heart condition.
Why stopping is so difficult
Venlafaxine has a short half-life, so levels fall quickly between doses and fall very quickly when it is stopped.
Discontinuation symptoms are consequently common and can be severe: dizziness, electric-shock sensations often described as brain zaps, nausea, sweating, irritability, anxiety, vivid dreams and flu-like aching.
They can start within a day of a missed dose - which is worth knowing, because people sometimes experience them mid-treatment simply from taking it late.
These are not addiction and they are not proof the medicine was doing nothing. They are a physiological adaptation reversing.
Coming off it
Reduction must be gradual and is often slower than people expect - over months rather than weeks, with smaller steps at lower doses where each reduction is a larger proportional change.
If a step is difficult, holding at that level for longer is the standard answer rather than pushing through.
Because the modified-release capsules cannot be split, the practical difficulty is finding small enough steps. Liquid preparations and alternative capsule strengths exist, and switching to fluoxetine - which tapers itself - is sometimes used as a bridge. See fluoxetine and coming off antidepressants safely.
Continue for at least six months after recovery before considering it, since stopping earlier substantially raises relapse risk.
Modified-release and immediate-release
Immediate-release tablets are taken twice daily; modified-release capsules once daily.
The modified-release form gives steadier levels and fewer between-dose symptoms, which is why it is generally preferred. Capsules must be swallowed whole - see cutting and crushing tablets.
The two are not interchangeable milligram for milligram in terms of how you take them, so check the instructions if your preparation changes.
Overdose
Venlafaxine is more toxic in overdose than SSRIs, causing seizures and heart rhythm disturbances.
That is a reason for careful storage and sometimes for smaller quantities being dispensed. Call 999 for any suspected overdose, even if the person seems well, and take the packaging.
If you are having thoughts of harming yourself, Samaritans are free on 116 123 at any hour, or you can text SHOUT to 85258.
Other side effects
Nausea is very common at the start and usually settles within a week or two - taking it with food helps.
Sweating is notably common with venlafaxine, often drenching and often persistent, and is a frequent reason people switch.
Headache, dry mouth, insomnia, constipation and dizziness occur. Sexual side effects are common and often persist - see antidepressants and sexual side effects.
Low sodium is a recognised effect, more likely in older people and those on diuretics, causing confusion and falls.
Interactions
Combining with other serotonergic medicines - tramadol, triptans, St John's wort, other antidepressants - raises the risk of serotonin syndrome. See tramadol.
Bleeding risk rises alongside anti-inflammatories, aspirin and anticoagulants; paracetamol is the safer choice.
Venlafaxine has little effect on CYP2D6, which makes it a reasonable antidepressant choice for someone taking tamoxifen - see tamoxifen.
Where it fits
Venlafaxine is generally a second-line antidepressant, used after an SSRI has not worked or has not been tolerated - not because it is less effective, but because the blood pressure monitoring and the discontinuation difficulty make an SSRI the simpler starting point.
It is licensed for depression and for generalised anxiety, panic and social anxiety disorder. Duloxetine is the other SNRI in common use, and is also licensed for neuropathic pain, which sometimes decides the choice where both problems coexist - see nerve pain medicines.
The first two weeks
Anxiety, restlessness, nausea and disturbed sleep are common early and usually settle. Benefit builds over four to six weeks.
Contact your prescriber urgently if you feel worse, more agitated, or have thoughts of harming yourself - most relevant in the first weeks and after any dose change, particularly under 25.
See also Mirtazapine: Why Lower Doses Sedate More, and the Medicines section for more on how the main families of medicine work.